Metabolite Profile of Treatment-Naive Metabolic Syndrome Subjects in Relation to Cardiovascular Disease Risk

Metabolite Profile of Treatment-Naive Metabolic Syndrome Subjects in Relation to Cardiovascular Disease Risk

Metabolic syndrome (MetSyn) is an important risk factor for type 2 diabetes and cardiovascular diseases (CVD). This study aimed to find distinct plasma metabolite profiles between insulin-resistant and non-insulin resistant subjects with MetSyn and evaluate if MetSyn metabolite profiles are related...

Full description

Bibliographic Details
Main Authors: Moritz V. Warmbrunn, Annefleur M. Koopen, Nicolien C. de Clercq, Pieter F. de Groot, Ruud S. Kootte, Kristien E. C. Bouter, Kasper W. ter Horst, Annick V. Hartstra, Mireille J. Serlie, Mariette T. Ackermans, Maarten R. Soeters, Daniel H. van Raalte, Mark Davids, Max Nieuwdorp, Albert K. Groen
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Metabolites
Subjects:
metabolic syndrome
metabolomics
cardiovascular disease
lipolysis
phospholipids
Online Access:https://www.mdpi.com/2218-1989/11/4/236

Similar Items

Similar Items